Spark Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Spark Investment Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-65,400	Closed	-$1.44M	–	578
2019 Q4	$1.44M	Sell	65,400 -16,500	-20%	-$332K	0.17%	175
2019 Q3	$1.18M	Sell	81,900 -41,972	-34%	-$600K	0.15%	169
2019 Q2	$1.95M	Buy	+123,872	New	+$1.68M	0.14%	201
2018 Q3	–	Sell	-100,200	Closed	-$1.23M	–	775
2018 Q2	$1.23M	Sell	100,200 -44,800	-31%	-$563K	0.07%	323
2018 Q1	$1.39M	Buy	+145,000	New	+$1.56M	0.09%	282
2015 Q3	–	Sell	-10,600	Closed	-$147K	–	783
2015 Q2	$147K	Buy	+10,600	New	+$194K	0.02%	570

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Spark Investment Management's DRNA Position: Q1 2020 in Review

Spark Investment Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q1 2020, closing a stake of 65,400 shares — an estimated $1.44M sold.

Spark Investment Management first reported a position in DRNA in Q2 2015 and held it in 6 quarters. The position peaked at $1.95M in Q2 2019. 144 funds tracked by Wall St. Rank hold DRNA as of Q1 2020.

Spark Investment Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Spark Investment Management sold 65,400 Dicerna Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.44M.
Spark Investment Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2015 and held it in 6 quarters.
Spark Investment Management's Dicerna Pharmaceuticals, Inc. position peaked at $1.95M in Q2 2019.
144 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.